Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Identification of host genes essential for SARS-CoV-2 infection may reveal novel therapeutic targets and inform our understanding of COVID-19 pathogenesis. Here we performed a genome-wide CRISPR screen with SARS-CoV-2 and identified known SARS-CoV-2 host factors including the receptor ACE2 and protease Cathepsin L. We additionally discovered novel pro-viral genes and pathways including the SWI/SNF chromatin remodeling complex and key components of the TGF-β signaling pathway. Small molecule inhibitors of these pathways prevented SARS-CoV-2-induced cell death. We also revealed that the alarmin HMGB1 is critical for SARS-CoV-2 replication. In contrast, loss of the histone H3.3 chaperone complex sensitized cells to virus-induced death. Together this study reveals potential therapeutic targets for SARS-CoV-2 and highlights host genes that may regulate COVID-19 pathogenesis.
Article activity feed
-
SciScore for 10.1101/2020.06.16.155101: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources After an incubation period of 1 hour at 37°C, the inoculum was removed and cells were washed with PBS before media supplemented with anti-VSV-G clone I4 was added in order to neutralize residual input virus (no antibody was added to cells expressing VSV-G). anti-VSV-Gsuggested: NoneExperimental Models: Cell Lines Sentences Resources Generation of SARS-CoV-2 stocks: To generate SARS-CoV-2 viral stocks, Huh7.5 cells were inoculated with SARS-CoV-2 isolate USA-WA1/2020 (BEI Resources #NR-52281) at an MOI of approximately 0.01 for three days to generate a P1 stock. Huh7.5suggested: RRID:CVCL_7927)Virus titer … SciScore for 10.1101/2020.06.16.155101: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources After an incubation period of 1 hour at 37°C, the inoculum was removed and cells were washed with PBS before media supplemented with anti-VSV-G clone I4 was added in order to neutralize residual input virus (no antibody was added to cells expressing VSV-G). anti-VSV-Gsuggested: NoneExperimental Models: Cell Lines Sentences Resources Generation of SARS-CoV-2 stocks: To generate SARS-CoV-2 viral stocks, Huh7.5 cells were inoculated with SARS-CoV-2 isolate USA-WA1/2020 (BEI Resources #NR-52281) at an MOI of approximately 0.01 for three days to generate a P1 stock. Huh7.5suggested: RRID:CVCL_7927)Virus titer was determined by plaque assay using Vero-E6 cells. Vero-E6suggested: NoneCas9 activity was assessed by transducing parental Vero-E6 or Vero-E6-Cas9 cells with pXPR_047 (Addgene 107645), which expresses eGFP and an sgRNA targeting eGFP (72). Vero-E6-Cas9suggested: NoneBriefly, 293T cells were transfected with pCAGGS vector expressing the SARS-CoV-2 spike glycoprotein and then inoculated with a replication-deficient VSV vector that contains expression cassettes for Renilla luciferase instead of the VSV-G open reading frame. 293Tsuggested: NCBI_Iran Cat# C498, RRID:CVCL_0063)Software and Algorithms Sentences Resources Screen analysis: Guide sequences were extracted from the sequencing reads with PoolQ version 3.2.9 (Broad Institute, https://portals.broadinstitute.org/gpp/public/software/poolq), using a “CACCG” search prefix, and a counts matrix was generated. PoolQsuggested: NoneGene set enrichment and network analysis: We used the STRING enrichment detection tool to identify significantly enriched gene sets, using African green monkey gene symbols, but testing for enrichment across human gene sets. STRINGsuggested: (STRING, RRID:SCR_005223)We analyzed sets from all available sources provided by that tool, including sets of clusters of proteinprotein interactors in STRING, and excluding the PubMed gene sets. PubMedsuggested: (PubMed, RRID:SCR_004846)Total cell numbers were quantified by Gen5 software of brightfield images. Gen5suggested: (Gen5, RRID:SCR_017317)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Importantly, this study is not without limitations as we used Vero-E6 cells, a type I interferon-deficient non-human primate cell line, rather than primary human cells (48–50). However, Vero-E6 cells are a model cell line for isolating viruses and were selected based on their susceptibility to SARS-CoV-2-induced death. Further, African green monkeys are susceptible to SARS-CoV-2 infection (19–21). Interestingly, we did not detect several genes previously implicated in SARS-CoV-2 infection including TMPRSS2, PIKFyve, and TPC2 suggesting that these genes are either not essential in a Vero cell-intrinsic manner or that functional redundancies exist with other genes (15, 45). Future work is necessary to evaluate the genes identified here in human cells and animal models. The abundance of genes identified here with functional roles in chromatin regulation and histone modification were surprising, as SARS-CoV-2 is an RNA virus that replicates in the cytoplasm. However, these genes highlight the potential importance of epigenetic regulation of SARS-CoV-2 infection and pathogenesis. Epigenetic processes have previously been implicated in regulating antigen presentation and interferon-stimulated gene induction after MERS-CoV and SARS-CoV infection (51–53); however, given that Vero-E6 cells are type I interferon-deficient, distinct mechanism(s) may be at play. Here we identify a novel role for HMGB1 in SARS-CoV-2 susceptibility. HMGB1 is a predominantly nuclear yet pleiotropic protein....
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-